Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Short-term Investments (2019 - 2023)

Bioadaptives' Short-term Investments history spans 5 years, with the latest figure at $11.0 for Q3 2023.

  • For Q3 2023, Short-term Investments fell 65.62% year-over-year to $11.0; the TTM value through Sep 2023 reached $11.0, down 65.62%, while the annual FY2022 figure was $42.0, 77.89% down from the prior year.
  • Short-term Investments for Q3 2023 was $11.0 at Bioadaptives, down from $21.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $3278.0 in Q1 2021 and bottomed at $11.0 in Q3 2023.
  • The 5-year median for Short-term Investments is $264.0 (2021), against an average of $556.83.
  • The largest annual shift saw Short-term Investments tumbled 96.3% in 2020 before it soared 1107.94% in 2021.
  • A 5-year view of Short-term Investments shows it stood at $772.0 in 2019, then crashed by 42.49% to $444.0 in 2020, then tumbled by 57.21% to $190.0 in 2021, then tumbled by 77.89% to $42.0 in 2022, then plummeted by 73.81% to $11.0 in 2023.
  • Per Business Quant, the three most recent readings for BDPT's Short-term Investments are $11.0 (Q3 2023), $21.0 (Q2 2023), and $32.0 (Q1 2023).